Testosterone during pregnancy linked to physical activity and muscle strength in children
Reports and Proceedings
Updates every hour. Last Updated: 16-May-2025 13:09 ET (16-May-2025 17:09 GMT/UTC)
Boys born to mothers who have polycystic ovary syndrome (PCOS) or who have higher levels of testosterone during the third trimester are more likely to be less physically active at age 7, according to research presented at the first Joint Congress between the European Society of Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE). Testosterone levels or PCOS in the mothers were not associated with physical activity in girls, but 7-year-old girls whose mothers had higher testosterone levels during pregnancy had lower muscle strength. The findings highlight the important role that maternal testosterone and PCOS may play in future development in boys and girls independently.
Three-year-old boys are more likely to have a shorter anogenital distance when their mothers have high levels of phthalates in their urine, according to research presented at the first Joint Congress between the European Society of Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE). In girls, the direct exposure to phthalates was associated with a shorter anogenital distance. The findings highlight how exposure to environmental pollutants can cause alterations in genital measurements during the first three years of life, which may affect sexual development and fertility later in life.
Girls given antibiotics during their first year of life, especially in the first three months, are more likely to enter puberty at an earlier age, according to research presented at the first Joint Congress between the European Society of Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE). The likelihood of early puberty was also higher among those exposed to a greater variety of antibiotic classes. The findings highlight the importance of using these medicines in infants appropriately and how early-life drug exposure could shape future health outcomes.
THE EUROPEAN SOCIETY FOR PAEDIATRIC ENDOCRINOLOGY AND THE EUROPEAN SOCIETY OF ENDOCRINOLOGY JOIN TOGETHER THIS WEEKEND FOR THEIR INAUGURAL JOINT CONGRESS – “CONNECTING ENDOCRINOLOGY ACROSS THE LIFE COURSE”
The first ever Joint Congress between the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) starts today, Saturday 10 May and runs until Tuesday 13 May 2025. This truly joint landmark event, ‘Connecting Endocrinology Across the Life Course’, brings together paediatric and adult endocrine specialists from across Europe and the rest of the world to meet, collaborate and celebrate endocrinology at The Bella Center in Copenhagen, Denmark.
The event provides a unique opportunity for learning new perspectives and enabling scientific exchanges, coupled with extensive networking opportunities to make new connections with colleagues working in endocrinology across the whole life course.
*Please mention the European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14) if using this research*
New research being presented at this year’s European Congress on Obesity (ECO 2025) highlights the need to support women and their families with overweight or obesity to optimise their health and weight before they become pregnant.